BIONET Therapeutics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	3,462	3,252	-	-
Enterprise Value	2,329	2,381	-	-
Last Close Price	49.45	46.45	-	-
PS Ratio	32.76	39.99	-	-
PB Ratio	2.75	2.51	-	-
P/TBV Ratio	2.75	2.51	-	-
EV/Sales Ratio	22.04	29.28	-	-
Net Debt / Equity Ratio	-0.90	-0.94	-0.99	-1.11
Net Debt / EBITDA Ratio	10.06	12.64	13.56	-
Net Debt / FCF Ratio	6.28	7.84	11.34	15.53
Asset Turnover	0.09	0.09	0.02	-
Inventory Turnover	3.84	5.31	-	-
Quick Ratio	28.40	23.02	43.60	9.95
Current Ratio	29.41	23.74	43.71	9.98
Return on Equity (ROE)	-9.23%	-9.46%	-12.95%	-
Return on Assets (ROA)	-6.56%	-6.57%	-8.26%	-
Return on Capital Employed (ROCE)	-9.40%	-7.70%	-7.40%	-25.70%
Earnings Yield	-2.90%	-2.65%	-	-
FCF Yield	-5.21%	-4.77%	-	-
Buyback Yield / Dilution	-81.39%	-280.50%	-1278.45%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.